# Willem Broekaert

> Willem Broekaert is a Series A investor at V-Bio Ventures backing Health Care and Therapeutics. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [V-Bio Ventures](https://shizune.co/investors/profile/v-bio-ventures)
- Location: Ghent, Belgium
- Total investments: 1
- Last investment: Nov 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/willem-broekaert-2220bb13/
- Website: https://v-bio.ventures/

Willem Broekaert is a Series A investor at V-Bio Ventures in Ghent focused on Health Care and Therapeutics. Willem Broekaert is the Managing Partner at V-Bio Ventures. He attended KU Leuven.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ATB Therapeutics | ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients. | $57.2M | Series A | Nov 18, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [EQT Life Sciences](https://shizune.co/investors/profile/life-sciences-partners) — VC Fund, 2 deals together
- [MRL Ventures Fund](https://shizune.co/investors/profile/mrl-venture-fund) — VC Fund, 1 deal together
- [Sambrinvest](https://shizune.co/investors/profile/sambr-invest) — VC Fund, 1 deal together
- [SFPIM](https://shizune.co/investors/profile/sfpim) — VC Fund, 1 deal together
- [VIVES Funds](https://shizune.co/investors/profile/vives-funds) — VC Fund, 1 deal together
- [WE International](https://shizune.co/investors/profile/we-international) — VC Fund, 1 deal together

## About V-Bio Ventures

VC Fund · Gent, Belgium

V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.

4 contacts available at V-Bio Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Shelley Margetson | Managing Partner | https://shizune.co/investors/profile/shelley-margetson |
| Willem Broekaert | Managing Partner | https://shizune.co/investors/profile/willem-broekaert |
| Christina Takke | Managing Partner | https://shizune.co/investors/profile/christina-takke |
| Ward Capoen | Partner | https://shizune.co/investors/profile/ward-capoen |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Willem Broekaert invest in?

Willem Broekaert invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Willem Broekaert last invest?

The most recent investment recorded for Willem Broekaert closed in Nov 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
